Trump's Pharma Tariffs Could Become India's Biggest Opportunity, Says Bernstein | Nandan Kulkarni

Can Donald Trump's proposed tariffs on generic drugs actually become a long-term positive for Indian pharmaceutical companies? In this exclusive conversation, Bernstein's Nandan Kulkarni explains why the market may be overlooking the bigger picture. From Sun Pharma, Zydus and Lupin's US manufacturing advantage to rising drug prices, innovation, and the sector's outlook for 2030, here's a deep dive into the future of Indian pharma and the stocks that could emerge as winners. control your money with economic times now. #etnow #indianpharma #sunpharma #zydus #lupin #donaldtrump #stockmarket #businessnews #pharmastocks YouTube Channel -    / @etnow   Subscribe To ET Now For Latest Updates On Stocks Market News , Business News, Company News, IPO & More | https://bit.ly/SubscribeToETNow Subscribe Now To Our Network Channels :- ET Now Swadesh:    / etnowswadesh   Times Now: http://goo.gl/U9ibPb Social Media Links :- Twitter - http://goo.gl/hA0vDt Facebook - http://goo.gl/5Lr4mC Website - https://www.etnownews.com Download our App for Breaking News: https://tinyurl.com/4y6e3u2e Follow us on Google News for latest updates ET Now: https://news.google.com/publications/... Times Now Navbharat: https://bit.ly/3zDaKJo Times Now : https://bit.ly/3CyrrYg Zoom: https://bit.ly/3CEK0dv